Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells
Background: Currently, there remains an incomplete view of cancer stem cells (CSCs) in solid tumours. Methods: We studied a panel of putative CSC surface markers (ALDH1A1, ABCG2, CD44v7/8, CD44v10, CD133, CD271, and Nestin) in 40 established melanoma cell lines and four early-passage melanoma strain...
Main Authors: | Lisa Speigl, Nicole Janssen, Benjamin Weide, Tobias Sinnberg, Graham Pawelec, Christopher Shipp |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-09-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/28/9/10.31083/j.fbl2809193 |
Similar Items
-
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients
by: Paula Kamińska, et al.
Published: (2023-03-01) -
Melanoma stem cell vaccine induces effective tumor immunity against melanoma
by: Qiliang Yin, et al.
Published: (2023-01-01) -
Cell-intrinsic ceramides determine T cell function during melanoma progression
by: Matthias Hose, et al.
Published: (2022-11-01) -
Role of Natural Killer Cells in Uveal Melanoma
by: Asad Javed, et al.
Published: (2020-12-01) -
Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy
by: Lindy Davis, et al.
Published: (2021-12-01)